Drug Type Small molecule drug |
Synonyms TAK 637, TAK637 |
Target |
Action antagonists |
Mechanism NK1R antagonists(Neurokinin 1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H25F6N3O2 |
InChIKeyLDXQLWNPGRANTO-UHFFFAOYSA-N |
CAS Registry217185-75-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Depressive Disorder, Major | Phase 2 | United States | - | - |
| Depressive Disorder, Major | Phase 2 | - | - | |
| Irritable Bowel Syndrome | Phase 2 | United States | - | - |
| Irritable Bowel Syndrome | Phase 2 | - | - | |
| Pollakisuria | Phase 2 | Europe | - | - |
| Urinary Bladder, Overactive | Phase 2 | - | - | |
| Urinary Incontinence | Phase 2 | United States | - | - |
| Urinary Incontinence | Phase 2 | Europe | - | - |





